Systematic review / meta-analysis / 2018
A meta-analysis of 228 trials found that probiotic efficacy is both strain-specific and disease-specific.
A systematic review and meta-analysis of 228 trials (1970-2017) assessed whether probiotic strains have strain- and disease-specific efficacy in preventive and treatment indications with at least two randomized controlled trials per indication. Significant efficacy evidence was found for 7 (70%) of probiotic strain(s) among four preventive indications and 11 (65%) probiotic strain(s) among five treatment indications. For preventing adult antibiotic-associated diarrhea, specific Lactobacillus preparations (such as Bio-K+, Actimel, and L. reuteri 55730) demonstrated efficacy while other Lactobacillus strains did not. Significant disease-specific variations in efficacy were also shown for L. rhamnosus GG and Saccharomyces boulardii CNCM I-745, among other strains.
- Study type
- Systematic review and meta-analysis
- Who was studied
- Participants across 228 randomized controlled trials
- What was measured
- Strain-specific and disease-specific probiotic efficacy across clinical indications
THE PAPER
Strain-Specificity and Disease-Specificity of Probiotic Efficacy: A Systematic Review and Meta-Analysis.
McFarland LV, Evans CT, Goldstein EJC. Front Med (Lausanne), 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.